Skip to main content
. 2023 Jul 17;16:4621–4633. doi: 10.2147/IDR.S417033

Table 4.

Antimicrobial Susceptibility Patterns of Gram Positive and Gram Negative Bacterial Isolate from Urine Sample at Dilla University Referral Hospital, from January 2022 to December 2022

Antimicrobial Agents Tested (Gram Negative)
Bacterial Isolate Total Pattern AMP AMC CIP CEF MER CRO DOX NIT CN SXT V PE
No (%)
No (%) No (%) No (%) No (%) No (%) No (%) No (%) No (%) No (%) No (%)
E. coli 7 S 0 (0.0) 1 (14.3) 4 (57.1) 5 (71.4) 7 (100) 6 (85.7) 1 (14.3) 6 (85.7) 5 (71.4) 5 (71.4) NA NA
I 0 (0.0) 0 (0.0) 1 (14.3) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
R 7 (100) 6 (85.7) 2 (27.6) 2 (27.6) 0 (0.0) 1 (14.3) 6 (85.7) 1 (14.3) 2 (27.6) 2 (27.6)
K. pneumoniae 3 S 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 2 (66.7) 1 (33.3) 0 (0.0) 7 (100) 2 (66.7) 2 (66.7) NA NA
I 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
R 3 (100) 3 (100) 3 (100) 3 (100) 1 (33.3) 2 (66.7) 7 (100) 0 (0.0) 1 (33.3) 1 (33.3)
Enterobacter species 2 S 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (50.0) 1 (50.0) 0 (0.0) 1 (100) 1 (50.0) 1 (50.0) NA NA
I 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
R 2 (100) 2 (100) 2 (100) 2 (100) 1 (50.0) 1 (50.0) 2 (100) 0 (0.0) 1 (50.0) 1 (50.0)
K. oxytoca 1 S 0 (0.0) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) NA NA
I 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
R 1 (100) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
P. mirabilis 1 S 0 (0.0) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 0 (0.0) 0 (0.0) NA NA
I 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
R 1 (100) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (100) 1 (100)
Citrobacter species 1 S 0 (0.0) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) 1 (100) NA NA
I 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
R 1 (100) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Antimicrobial Agents Tested (Gram Positive)
CoNS 5 S 0 (0.0) 1 (20.0) 4 (80.0) 2 (40.0) NT NT NT 4 (80.0) 3 (60.0) 4 (60.0) 1 (100) 2 (40.0)
I 0 (0.0) 2 (40.0) 0 (40.0) 0 (0.0) 0 (0.0) 1 (20.0) 1 (20.0) 0 (0.0) 0 (0.0)
R 5 (100) 2 (40.0) 1 (20.0) 3 (60.0) 1 (20.0) 1 (20.0) 0 (0.0) 0 (0.0) 3 (60.0)
S. aureus 3 S 0 (0.0) 1 (33.3) 2 (66.7) 1 (33.3) NT NT NT 2 (66.7) 1 (33.3) 2 (66.7) 1 (100) 1 (33.3)
I 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
R 5 (100) 2 (66.7) 1 (33.3) 2 (66.7) 1 (33.3) 2 (66.7) 1 (33.3) 0 (0.0) 2 (66.7)
Enterococcus species 1 S 1 (100) 0 (0.0) 1 (100) 0 (0.0) NT NT NT 1 (100) NT NT NT 0 (0.0)
I 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
R 0 (0.0) 1 (100) 0 (0.0) 1 (100) 0 (0.0) 1 (100)

Abbreviations: CoNS, Coagulase negative Staphylococci; S, Sensitive; I, Intermediate; R, Resistance; AMC, Amoxicillin-clavulanic acid; AMP, Ampicillin; CEF, Ceftazidime; CRO, Ceftriaxone; CIP, Ciprofloxacin; DOX, Doxycycline; MER, Meropenem; NIT, Nitrofurantion; CN, Gentamicin; P, Penicillin; SXT, Trymethoprim-Sulfamethoxazole; V, Vancomycine; No, Number; NT, Not tested.